Jan Bińkowski

Mr. Jan Bińkowski

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2022 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
KSKatarzyna Ewa Sokolowska
Katarzyna Ewa Sokolowska
Dominika Maciejewska-MarkiewiczDominika Maciejewska-Markiewicz
Dominika Maciejewska-Markiewicz
JBJan Bińkowski
Jan Bińkowski
JPJoanna Palma
Joanna Palma
OTOlga Taryma-Lesniak
Olga Taryma-Lesniak
ESEwa Stachowska
Ewa Stachowska
Background: High caloric diet and lack of physical activity are considered main causes of NAFLD, and a change in the diet is still the only effective treatment of this disease. However, molecular mechanism of the effectiveness of diet change in treatment of NAFLD is poorly understood. We aimed to assess the involvement of epigenetic mechanisms of gene expression regulation in treatment of NAFLD. Eighteen participants with medium- to high-grade steatosis were recruited and trained to follow the Mediterranean diet modified to include fibre supplements. At three timepoints (baseline, after 30 and 60 days), we evaluated adherence to the diet and measured a number of physiological parameters such as anthropometry, blood and stool biochemistry, liver steatosis and stiffness. We also collected whole blood samples for genome-wide methylation profiling and histone acetylation assessment. Results: The diet change resulted in a decrease in liver steatosis along with statistically significant, but a minor change in BMI and weight of our study participants. The epigenetic profiling of blood cells identified significant genome-wide changes of methylation and acetylation with the former not involving regions directly regulating gene expression. Most importantly, we were able to show that identified blood methylation changes occur also in liver cells of NAFLD patients and the machine learning-based classifier that we build on those methylation changes was able to predict the stage of liver fibrosis with ROC AUC = 0.9834. Conclusion: Methylomes of blood cells from NAFLD patients display a number of changes that are most likely a consequence of unhealthy diet, and the diet change appears to reverse those epigenetic changes. Moreover, the methylation status at CpG sites undergoing diet-related methylation change in blood cells stratifies liver biopsies from NAFLD patients according to fibrosis grade.

13 July 2022 in Cancers
Verified
Journal Article
Open access
PDF file
KŁKarolina Łuczkowska
Karolina Łuczkowska
OTOlga Taryma-Lesniak
Olga Taryma-Lesniak
JBJan Bińkowski
Jan Bińkowski
KSKatarzyna E. Sokołowska
Katarzyna E. Sokołowska
DSDominik Strapagiel
Dominik Strapagiel
Tomasz K WojdaczTomasz K Wojdacz
Tomasz K Wojdacz
Bortezomib (BTZ) is proteasome inhibitor, effectively used in the treatment of multiple myeloma, but frequently discontinued due to peripheral neuropathy, which develops in patients after consecutive treatment cycles. The molecular mechanisms affected by BTZ in neuronal cells, which result in neuropathy, remain unknown. However, BTZ is unlikely to lead to permanent morphological nerve damage, because neuropathy reverses after discontinuation of treatment, and nerve cells have very limited renewal capacity. We have previously shown that BTZ induces methylation changes in SH-SY5Y cells, which take part in the development of treatment resistance. Here, we hypothesized that BTZ affects the methylomes of mature neurons, and these changes are associated with BTZ neurotoxicity. Thus, we studied methylomes of neuronal cells, differentiated from the LUHMES cell line, after cycles of treatment with BTZ. Our results show that BTZ induces specific methylation changes in mature neurons, which are not present in SH-SY5Y cells after BTZ treatment. These changes appear to affect genes involved in morphogenesis, neurogenesis, and neurotransmission. Furthermore, identified methylation changes are significantly enriched within binding sites of transcription factors previously linked to neuron physiology, including EBF, PAX, DLX, LHX, and HNF family members. Altogether, our results indicate that methylation changes are likely to be involved in BTZ neurotoxicity.

4 September 2025 in International Journal of Surgery
Verified
Journal Article
Open access
Tomasz KlepinowskiTomasz Klepinowski
Tomasz Klepinowski
PPPatrycja Przybyłowicz
Patrycja Przybyłowicz
OTOlga Taryma-Lesniak
Olga Taryma-Lesniak
JBJan Bińkowski
Jan Bińkowski
DLDagmara Lisman
Dagmara Lisman
LSLeszek Michał Sagan
Leszek Michał Sagan
Background: The molecular mechanisms underlying aneurysmal subarachnoid hemorrhage (aSAH) and delayed ischemic neurologic deficit (DIND) remain poorly understood. We hereby present the study investigating epigenome-wide profile of DNA methylation in adults with aSAH and DIND. Methods: A prospective observational epigenome-wide association study (EWAS) was conducted with DNA extracted from the peripheral whole blood of subjects with aSAH. DNA methylation profiling was conducted using Infinium MethylationEPIC v2.0 BeadChip microarray with a total number of 814 206 probes. Healthy matched controls were obtained from the publicly available dataset (GSE246337, n = 500) with 1:1 matching. DIND was determined by a combination of clinical symptoms and radiographic vasospasm. Differentially methylated probes (DMPs) were identified using linear regression model with Benjamini-Hochberg correction. This study was registered with ClinicalTrials.gov (NCT06881329). Results: 122 participants were included: 61 prospectively recruited with aSAH and 61 external age-, sex-, race-, and ethnicity-matched controls. Among aSAH patients, 32 developed DIND (52%). Overall, with linear regression, we identified 2642 DMPs associated with aSAH after multiple testing correction, and the lack of significant DIND-associated methylation changes. Specifically, as the top hit, we detected significant hypomethylation of cg15004555 (Δβ = −0.254) in aSAH patients, annotated to exon 2 of AIM2 , a gene whose expression is critical for AIM2-driven inflammasome activation. The functional enrichment analysis revealed that genes associated with the identified methylation changes were enriched in ontology terms related to specific biological processes such as immune response, pain modulation, phosphorus metabolism, as well as cellular components including cis-Golgi network or beta-catenin complex. Conclusions: Our prospective observational EWAS identified significant DNA methylation changes in the blood cells and demonstrated a functional link to specific biological processes in aSAH. Further validation studies are necessary to confirm our findings.